Top broker names Appen (ASX:APX) share price as a buy

The Appen share price has lost half of its value this year. Is this a buying opportunity?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Appen Ltd (ASX: APX) share price certainly has been out of form in 2021.

Since the start of the year, the artificial intelligence data services company's shares are down 50%.

This compares to a 12% gain by the S&P/ASX 200 Index (ASX: XJO) over the same period.

man on phone researching Fintech reports

Image source: Getty Images

Why is the Appen share price under pressure on 2021?

Investors have been selling down the Appen share price this year due to the impact that COVID-19 was having on demand for its services.

In May Appen's CEO, Mark Brayan, commented: "COVID interrupted many businesses last year and that in turn reduced their digital ad spend for a period. This impacted our major customers' sources of revenue, and although digital ad spend has bounced back nicely, that experience is driving them to invest in new AI products that are less reliant on advertising."

Also weighing on the Appen share price were comments about data privacy and anti-trust concerns that were impacting developments.

Mr Brayan said: "Our customers are developing new AI products in response to COVID's impact on online advertising last year and regulatory pressures such as anti-trust and data privacy. This dictates the data they need for product development and impacts their engineering resource allocations and the volumes and types of data they need from us."

"As stated before, machine learning is an iterative process, and our customers are switching resources between development projects as they pursue new break-out products. This in turn has impacted a handful of our larger programs," he added.

Is this a buying opportunity?

One leading broker that believes the weakness in the Appen share price could be a buying opportunity is Citi.

A note from this month reveals that its analysts have retained their buy rating and $18.80 price target on the company's shares.

This is despite the broker suspecting that a slower recovery in demand could lead to Appen falling short of the market's first half EBITDA estimates this month due to lower margins.

Citi is expecting EBITDA of US$27 million for the half, which is ~20% lower than consensus estimates.

Based on the current Appen share price of $12.71, Citi's price target implies potential upside of 48% over the next 12 months.

Citi is more positive on its longer term prospects. It believes Appen is well placed to benefit from the higher spending on artificial intelligence in the future. It also expects the company to leverage its increased capabilities and expand its addressable market.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Appen Ltd. The Motley Fool Australia owns shares of and has recommended Appen Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

Happy investor on tablet with finance graphs rising in overlay.
Technology Shares

WiseTech shares are taking off: Is this the start of a major comeback?

Strong FY26 results could trigger a major WiseTech valuation rethink.

Read more »

A couple sit in front of a laptop reading ASX shares news articles and learning about ASX 200 bargain buys
Earnings Results

FINEOS swings to profit in 1H26

FINEOS posted higher revenue, swung to profit, and outlined growth plans.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

Megaport shares are up more than 100% in 3 months. Are they still a buy?

Can the AI hype drive this stock even higher?

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Broker Notes

Up 250%! Broker tips this dividend paying ASX All Ords tech stock for more outsized gains

A top broker forecasts more outperformance from this dividend paying ASX tech stock.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Technology Shares

Bravura Solutions FY26 earnings: Revenue, profit, and dividends climb

Bravura Solutions surged 13% yesterday after releasing the result.

Read more »

A line up of job interview candidates sit in chairs against a wall clutching CVs on paper in an office setting.
Technology Shares

Seek shares plunge 14% despite solid results: Did investors overreact?

The market may be pricing in slower growth, weaker guidance and long-term AI disruption.

Read more »

Man analysing data on his laptop.
Technology Shares

Why this could be the best ASX tech stock to buy and hold

Xero already has almost five million customers, but I think there is still plenty of room for the business to…

Read more »

Businesswoman with a pleased smile reading on her laptop at a desk in the office with a look of satisfaction.
Technology Shares

Pro Medicus lands $23m St. Luke's Health System imaging contract

St. Luke’s Health System is Idaho’s largest private employer and not-for-profit healthcare provider.

Read more »